Loading patent…
AssigneeDaewoong Pharmaceutical Co., Ltd.
InventorsSun-Hwa Park, Joon Seok Park, Ji-Soo Choi, Hye Young Ji, Min-Ho Oak, Ju-Young Ko, Saugat Shiwakoti, Dhakal Bikalpa
Estimating the term…
The present invention relates to a pharmaceutical composition for use in preventing or treating cardiovascular aging diseases, comprising enavogliflozin as an active ingredient. Enavogliflozin of the present invention exhibits excellent effects in the prevention and treatment of endothelial dysfunction caused by vascular endothelial senescence, and cardiovascular aging diseases related thereto.
A method of preventing or treating senescence-related cardiovascular diseases in a subject in need thereof, comprising:
A pharmaceutical composition for use in preventing or treating senescence-related cardiovascular diseases, comprising enavogliflozin as an active ingredient.
Dependencies are inferred from the claim text.